- Acute Migraine Treatments PA Form 470-4113
- Adenosine Triphosphate Citrate Lyase Inhibitors PA Form 470-4113
- Age Edit Override Codeine or Tramadol PA Form 470-5507
- Alpelisib (Vijoice) PA Form 470-5730
- Alpha1 Proteinase Inhibitor Enzymes PA Form 470-5365
- Amylino Mimetic PA Form 470-4406
- Antidepressant PA Form 470-5098
- AntiDiabetic NonInsulin Agents PA Form 470-5259
- Antiemetic-5HT3 Receptor Antagonists-Substance P Neurokinin Agents PA Form 470-4410
- Anti-Fungal PA Form 470-4094
- Antihistamines PA Form 470-4095
- Apremilast (Otezla) PA Form 470-5293
- Aripiprazole Tablets with Sensor (Abilfy MyCite) PA Form 470-5600
- Baclofen PA Form 470-5694
- Benzodiazepines PA Form 470-4117
- Binge Eating Disorder Agents PA Form 470-5336
- Biologicals For Arthritis PA Form 470-4522
- Biologicals For Axial Spondyloarthritis PA Form 470-4521
- Biologicals For Hidradenitis Suppurativa PA Form 470-5408
- Biologicals For Inflammatory Bowel Disease PA Form 470-4523
- Biologicals For Plaque Psoriasis PA Form 470-4524
- Calcifediol (Rayaldee) PA Form 470-5487
- Cholic Acid (Cholbam) PA Form 470-5391
- CNS Stimulants and Atomoxetine PA Form 470-4116
- Crisaborole (Eucrisa) PA Form 470-5488
- Cyclosporine Ophthalmic 0.1% Emulsion (Verkazia) PA Form 470-5779
- Cystic Fibrosis Agents Oral PA Form 470-5627
- Dalfampridine (Ampyra) PA Form 470-5015
- Deferasirox (Exjade) PA Form 470-5330
- Deucravacitinib (Sotyktu) PA Form 470-5797
- Dextromethorphan and Quinidine (Nuedexta) PA Form 470-5084
- Direct Oral Anticoagulants PA Form 470-5423
- Dupilumab (Dupixent) PA Form 470-5497
- Duplicate Therapy Override PA Form 470-5460
- Eluxadoline (Viberzi) PA Form 470-5410
- Erythropoesis Stimulating Agents PA Form 470-4098
- Extended Release Formulation PA Form 470-4550
- Fentanyl Short-Acting Products PA Form 470-4092
- Fifteen Day Initial Prescription Supply Override PA Form 470-5038
- Finerenone (Kerendia) PA Form 470-5716
- GLP-1 Agonist Basal Insulin Combinations PA Form 470-5490
- Gonadotropin Releasing Hormone (GnRH) Receptor Antagonist Oral PA Form 470-5578
- Granulocyte Colony Stimulating Factor PA Form 470-4099
- Growth Hormone PA Form 470-4100
- Hematopoietics Chronic ITP PA Form 470-4850
- Hepatitis C Treatments Direct Acting Antivirals PA Form 470-5270
- High Dose Opioids PA Form 470-5531
- IL5 Antagonists PA Form 470-5424
- Immunomodulators Topical PA Form 470-5040
- Initial Days Supply Limit Override PA Form 470-5672
- Isotretinoin Oral PA Form 470-4101
- Ivabradine (Corlanor) PA Form 470-5409
- Janus Kinase Inhibitors PA Form 470-5175
- Ketorolac PA Form 470-4102
- Korlym (mifepristone) PA Form 470-5141
- Letermovir (Prevymis) PA Form 470-5548
- Lidocaine Patch PA Form 470-4898
- Linezolid (Zyvox) PA Form 470-4275
- Long Acting Opioids PA Form 470-4409
- Mannitol Inhalation Powder (Bronchitol) PA Form 470-5670
- Maralixibat (Livmarli) PA Form 470-5731
- Mavacamten (Camzyos) PA Form 470-5732
- Methotrexate Injection PA Form 470-5294
- Miconazole Zinc Oxide White Petrolatum (Vusion) Ointment PA Form 470-4655
- Miscellaneous PA Form 470-4104
- Modified Formulations PA Form 470-4705
- Multiple Sclerosis Agents Oral PA Form 470-5060
- Muscle Relaxants PA Form 470-4105
- Narcotic Agonist Antagonist Nasal Spray PA Form 470-4106
- New to Market Drugs PA Form 470-5492
- Nocturnal Polyuria Treatments PA Form 470-5577
- Non-Parenteral Vasopressin Derivatives PA Form 470-4107
- Non-Preferred Drug PA Form 470-4108
- Nonsteroidal Anti-Inflammatory Drugs PA Form 470-4109
- Odevixibat (Bylvay) PA Form 470-5717
- Omalizumab (Xolair) PA Form 470-4279
- Ophthalmic Agents for Presbyopia PA Form 470-5718
- Oral Constipation Agents PA Form 470-5718
- Oral Glucocorticoids for Duchenne Muscular Dystrophy PA Form 470-5489
- Oral Immunotherapy PA Form 470-5295
- Ospemifene (Osphena) PA Form 470-5601
- Pavilizumab PA Form 470-4110
- PCSK9 Inhibitors PA Form 470-5399
- Peanut (Arachis Hypogaea) Allergen Powder-dnfp (Palforzia) PA Form 470-5637
- Pegcetacoplan (Empaveli) PA Form 470-5715
- Pirfenidone (Esbriet) and Nintedanib (Ofev) PA Form 470-5346
- Proton Pump Inhibitors PA Form 470-4112
- Pulmonary Arterial Hypertension Agents PA Form 470-4327
- Quantity Limit Override PA Form 470-4566
- Repository Corticotropin Injection PA Form 470-5172
- Rifaximin (Xifaxan) PA Form 470-5411
- Risdiplam (Evrysdi) PA Form 470-5671
- Roflumilast (Daliresp) PA Form 470-5085
- Sapropterin (Kuvan) PA Form 470-5493
- Satralizumab (Enspryng) PA Form 470-5652
- Sedative Hypnotic Non-Benzodiazpine PA Form 470-4328
- Select Anticonvulsants PA Form 470-5591
- Select Non-Biologic Agents for Ulcerative Colitis PA Form 470-5683
- Select Oncology Agents PA Form 470-5367
- Select Topical Psoriasis Agents PA Form 470-5739
- Selected Brand Name Drugs PA Form 470-5039 & 470-4119
- Selective Preventative Migraine Treatments PA Form 470-5554
- Short Acting Opioids PA Form 470-4899
- Sodium Oxybate Products PA Form 470-5016
- Tasimelteon (Hetlioz) PA Form 470-5296
- Testosterone Products PA Form 470-5188
- Tezepelumab-ekko (Tezspire) Prefilled Pen PA Form 470-5798
- Topical Acne and Rosacea Products PA Form 470-5426
- Topical Antifungals for Onychomycosis PA Form 470-5368
- Topical Corticosteroids PA Form 470-5347
- Tralokinumab-ldrm (Adbry) PA Form 470-5719
- Triheptanoin (Dojolvi) PA Form 470-5693
- Vericiguat (Verquvo) PA Form 470-5685
- Vesicular Monoamine Transporter (VMAT) 2 Inhibitors PA Form 470-5534
- Viloxazine (Qelbree) PA Form 470-5684
- Vitamins Minerals and Multiple Vitamins PA Form 470-4115
- Zuranolone (Zurzuvae) PA Form 470-0123
